7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease

NCT01704404 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: TD-4208
DRUG: Placebo

Sponsor

Mylan Inc.

Collaborators

[object Object]